Elicio Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Elicio Therapeutics announces its annual stockholders meeting to be held virtually on May 19, 2025, featuring the election of directors and ratification of the company's independent accounting firm.
NASDAQ
DEF 14A: Elicio Therapeutics Seeks Stockholder Approval for Key Proposals at Upcoming Annual Meeting
Elicio Therapeutics is holding its Annual Meeting of Stockholders on November 7, 2024, to elect directors, ratify the selection of its accounting firm, and approve the issuance of shares related to warrants and a convertible note.